Olanzapine for the Treatment of Refractory Chronic Nausea and Vomiting
NCT02977741 · Status: WITHDRAWN · Type: OBSERVATIONAL
Last updated 2018-08-20
Summary
Prospective, observational study evaluating the effect of olanzapine for the treatment of refractory chronic nausea and vomiting.
Conditions
Interventions
- DRUG
Sponsors & Collaborators
- lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-11-30
- Primary Completion
- 2017-12-31
- Completion
- 2017-12-31
Countries
- United States
Study Locations
More Related Trials
-
Domperidone for the Treatment of Chronic Nausea and Vomiting Secondary to Gastroparesis
NCT01711918 ·Status: COMPLETED ·Phase: NA
-
Domperidone for Chronic Nausea and Vomiting
NCT02757534 ·Status: NO_LONGER_AVAILABLE
-
Oral Disintegrating Ondansetron Tablet to Reduce Vomiting From Gastroenteritis in a Pediatric Emergency Department
NCT00120744 ·Status: COMPLETED ·Phase: NA
-
12 Weeks Treatment With DDP225 or Placebo in Patients With Chronic Functional Vomiting
NCT00252993 ·Status: TERMINATED ·Phase: PHASE2
-
Patient Education in Preventing Nausea and Vomiting in Cancer Patients Receiving Chemotherapy
NCT00005994 ·Status: COMPLETED ·Phase: NA
-
The Effects of Ondansetron on Brain Function
NCT02460341 ·Status: COMPLETED ·Phase: PHASE1
-
Vestibular Dysfunction as a Cause of Chronic Nausea & Vomiting: A Follow up Survey
NCT01378351 ·Status: TERMINATED
-
Olanzapine Plus Metoclopramide for the Prevention of Opioid-Induced Nausea and Vomiting
NCT07208305 ·Status: RECRUITING ·Phase: PHASE3
-
Aprepitant for the Relief of Nausea in Patients With Chronic Nausea and Vomiting of Presumed Gastric Origin Trial
NCT01149369 ·Status: COMPLETED ·Phase: PHASE2
-
Intravenous Haloperidol Versus Ondansetron for Treatment of Established Post-operative Nausea and Vomiting
NCT02143531 ·Status: COMPLETED ·Phase: PHASE4
-
Pharmacogenetic Study of Ondansetron in Alcohol Use Disorder
NCT02354703 ·Status: COMPLETED ·Phase: PHASE2
-
Comparison of Antiemetic Drugs in Preventing Delayed Nausea After Chemotherapy in Patients With Cancer
NCT00020657 ·Status: COMPLETED ·Phase: PHASE3
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Non-Fasting Conditions
NCT00947128 ·Status: COMPLETED ·Phase: PHASE1
-
To Demonstrate the Relative Bioavailability Study of Ondansetron HCl 24 mg Tablets Under Fasting Conditions
NCT00946387 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of 10mg Domperidone on Gastric Emptying of a High-fat Meal and Appetite Sensations in Healthy Adults
NCT01347814 ·Status: COMPLETED ·Phase: NA
-
A Study to Evaluate the Safety and Efficacy of Domperidone in Pediatric Participants With Nausea and Vomiting Due to Acute Gastroenteritis
NCT02699385 ·Status: TERMINATED ·Phase: PHASE3
-
The Use Of Domperidone For The Relief Of Refractory Upper Gastrointestinal GI Symptoms
NCT03810287 ·Status: NO_LONGER_AVAILABLE
-
Antiemetic Fosaprepitant To Remedy Nausea and Vomiting
NCT06382012 ·Status: RECRUITING ·Phase: PHASE2/PHASE3
-
Decreasing the Incidence of Post-Operative Nausea and Vomiting (PONV) in Bariatric Patients
NCT00956215 ·Status: COMPLETED ·Phase: NA
-
Safety and Efficacy of Palonosetron IV to Prevent Postoperative Nausea and Vomiting in Pediatric Patients
NCT01395901 ·Status: COMPLETED ·Phase: PHASE3
-
TReatment of Irritable Bowel Syndrome With Diarrhoea Using Titrated ONdansetron Trial
NCT03555188 ·Status: COMPLETED ·Phase: PHASE3
-
Symptomatic Treatment of Acute Gastroenteritis
NCT01257672 ·Status: COMPLETED ·Phase: PHASE3
-
Effectiveness of Electrical Neurostimulation in Cyclic Vomiting Syndrome.
NCT04721171 ·Status: TERMINATED ·Phase: NA
-
Effects of Ondansetron Dose and Timing on Post-operative Nausea and Vomiting
NCT03297021 ·Status: COMPLETED ·Phase: PHASE4
-
Bioavailability Study of Ondansetron 24 mg Orally Disintegrating Tablets Under Fasting Conditions
NCT00659074 ·Status: COMPLETED ·Phase: PHASE1